Palm Beach Gardens doctor is first in Florida to use HeartLight® Endoscopic Ablation System for the treatment of AFib
Palm Beach Gardens, Fla. – January 18, 2018 – There is new hope for South Florida residents who suffer from atrial fibrillation (AFib), the most common type of heart arrhythmia. Cardiac electrophysiologist, Dr. David Weisman will offer a new, FDA-approved, laser balloon treatment option known as the HeartLight® Endoscopic Ablation System by Cardiofocus®. Dr. Weisman is the first and only cardiac electrophysiologist in the state of Florida using the HeartLight® Endoscopic Ablation System to treat heart arrhythmias associated with AFib. This minimally invasive treatment option is used for AFib patients whose heart arrhythmias cannot be controlled with medication. The outpatient procedure typically takes less than three hours and in most cases patients can go home from the hospital the very next day.
“This is an exciting development in the treatment of AFib. Before the HeartLight System, we had to rely on X-ray or mapping support for guidance. With this new technology we are able to see the exact area where the problem is occurring and treat it,” said Dr. Weisman. “We are extremely pleased with the results we’ve seen so far and are thrilled to offer this next-generation, effective therapy to AFib patients in South Florida.”
Dr. Weisman maneuvers the HeartLight System electrophysiology equipment into the heart via a minimally invasive groin incision, to deliver precise and controlled laser energy to diseased areas of the heart. He said that the HeartLight System is the latest technology on the market for the treatment of AFib. The unique benefit of this ablation system, versus other options on the market, is the availability of the visually guided laser balloon technology to control laser treatment consistently during pulmonary vein isolation (PVI) for AFib treatment.
“Patient safety is my ultimate goal. Last year, I shared the fact that I’m conducting cardiac ablations without the use of fluoroscopy or X-ray. The HeartLight System is yet another safe and effective treatment option I can provide to my patients whose heart arrhythmias are insufficiently controlled with medication,” said Dr. Weisman.
“We have is a revolutionary new way to visualize and ablate the heart using the Heartlight® Endoscope Ablation System, which was not previously available to patients,” said Dr. Weisman.
About Tenet Florida Physician Services
Tenet Florida Physician Services (TFPS), a division of Tenet Healthcare Corporation, is a multi-specialty physician group that has provided care to the communities of Palm Beach, Broward and Miami-Dade counties since 2007. TFPS physicians, including primary care, specialists and sub-specialists, have cared for over 625,000 patients across various medical and surgical specialties. Our award-winning physicians provide a level of expertise that has resulted in regional firsts and outstanding patient outcomes. TFPS physicians and staff are committed to delivering high quality care. Our mission is to improve the life of every person who enters our doors. Today, we are proud to be one of the largest and most respected physician networks in the area.
About Tenet Florida Heart & Vascular Network
The Tenet Heart & Vascular Network is a network of highly skilled cardiologists and cardiovascular surgeons using advanced heart care technology to provide exceptional patient heart care in Tenet Florida’s 10-hospital system and TFPS specialty physician groups across South Florida.
About Atrial Fibrillation
An arrhythmia is a problem with the rate or rhythm of the heartbeat – the heart can beat too fast, too slow, or at an irregular pace. AF occurs if rapid, disorganized electrical signals cause the heart’s two upper chambers (called the atria) to beat very fast and irregularly. In addition to uncomfortable symptoms, if left untreated, AF can lead to blood clots, stroke, heart failure and other heart-related complications. Medications may help reduce the symptoms; however in many cases these medications are not enough to keep AF under control and may have serious side effects. AF affects nearly 2.3 million people in the United States, and the numbers are climbing along with the growing elderly population.
About the HeartLight Endoscopic Ablation System
The HeartLight Endoscopic Ablation System is a revolutionary catheter ablation technology designed for the treatment of atrial fibrillation (AF), the most common heart arrhythmia. The HeartLight System’s direct visualization, titratable laser energy, and universal balloon design make it a new standard for pulmonary vein isolation (PVI) procedures. The device received CE Mark in 2009 and U.S. FDA approval in April 2016. In the U.S., the HeartLight System is indicated for the treatment of drug refractory recurrent symptomatic paroxysmal AF. More than 2.3 million people in the United States suffer from AF, and the numbers are climbing along with the growing older population.2 More than 4,500 patients with AF have been successfully treated with the system.
About CardioFocus, Inc.
CardioFocus Inc. is a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as Atrial Fibrillation (AF). The company’s HeartLight® Endoscopic Ablation System is commercially available at leading institutions throughout the United States and Europe. CardioFocus is headquartered in Marlborough, Mass. For more information, visit www.cardiofocus.com.
# # #
Media: David DiPino, O: 561-288-4741 | C: 561-212-4368